From “I just want to live” to “Yes, I will live”: Anas battles Duchenne muscular dystrophy with hope

At Al Jalila Children's Hospital, the story of Anas Mohamed Allam is framed as a journey from fear toward hope. The Egyptian child is confronting Duchenne muscular dystrophy, while his parents remain beside him through treatment and the daily challenges of a disease that gradually weakens the muscles and reduces mobility.

Anas received Elevidys, one of the world's most expensive treatments, at a cost of Dhs10.6 million. The therapy is delivered in a single intravenous session and introduces a functional version of the dystrophin gene directly into the patient's cells.

Duchenne muscular dystrophy is a neuromuscular condition caused by a defect in the dystrophin protein. Elevidys is intended to help the body produce this crucial protein, which supports muscle strength. For Anas and his family, the treatment represents a medical intervention carried out against a steadily progressive illness, with his parents providing what the article describes as a foundation of courage and comfort.